| Bioactivity | M2e, human TFA, consisting of the 23 extracellular residues of M2 (the third integral membrane protein of influenza A), has been remarkably conserved in all human influenza A. M2e, human TFA is a valid and versatile vaccine candidate to protect against any strain of human influenza A[1]. | ||||||
| Name | M2e, human TFA | ||||||
| Sequence | Ser-Leu-Leu-Thr-Glu-Val-Glu-Thr-Pro-Ile-Arg-Asn-Glu-Trp-Gly-Cys-Arg-Cys-Asn-Asp-Ser-Ser-Asp | ||||||
| Shortening | SLLTEVETPIRNEWGCRCNDSSD | ||||||
| Formula | C109H171F3N32O43S2 | ||||||
| Molar Mass | 2738.83 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
M2e, human TFA
CAS: F: C109H171F3N32O43S2 W: 2738.83
M2e, human TFA, consisting of the 23 extracellular residues of M2 (the third integral membrane protein of influenza A),
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.